Home LiteratureArticle Details
PMID: 8595146 Published · ppublish English Journal Article Review

Potential for protein kinase C inhibitors in cancer therapy.

Cancer treatment and research ·Vol. 78 ·1995-00-00 ·Pages 3-27

Philip PA, Harris AL

Abstract

暂无摘要

MeSH Terms
Animals Antineoplastic Agents/therapeutic use Bryostatins DNA Topoisomerases, Type I/metabolism Drug Resistance Enzyme Inhibitors/therapeutic use Humans Lactones/therapeutic use Macrolides Neoplasms/drug therapy,enzymology Protein Kinase C/antagonists & inhibitors,physiology Tetradecanoylphorbol Acetate/pharmacology
Chemicals
Antineoplastic Agents Bryostatins Enzyme Inhibitors Lactones Macrolides bryostatin 1 Protein Kinase C DNA Topoisomerases, Type I Tetradecanoylphorbol Acetate
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Philip P A
Division of Hematology and Oncology, Harper Hospital, Detroit, MI 48201, USA.
Harris A L
Article Info
Journal
Cancer treatment and research
Abbr.
Cancer Treat Res
ISSN
0927-3042
DOI
10.1007/978-1-4615-2007-8_1
Published
1995-00-00
Pages
3-27
Language
English
Region
United States
NLM ID
8008541
Subset
IM
External Links
PubMed source DOI: 10.1007/978-1-4615-2007-8_1
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2